One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease

NCT02240121 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
80
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early due to difficulty in enrollment and lack of clinical study drug access.

Conditions

Interventions

Sponsor

Bausch Health Americas, Inc.

Collaborators